Epithelial damage and angiogenesis in the airways of children with asthma

Angelo Barbato1, Graziella Turato, Simonetta Baraldo

  • 1Divisione di Pneumologia, Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari Università degli Studi di Padova, via Giustiniani 3, Padova, Italy.

Insights

Childhood asthma shows airway remodeling, including epithelial damage and thickened basement membranes, similar to adults. These changes, along with eosinophilia, appear early in the disease and may also indicate atopy without asthma symptoms.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Immunology

Background:

  • Airway remodeling and inflammation are hallmarks of adult asthma.
  • These pathological features are under-investigated in pediatric asthma cases.

Purpose of the Study:

  • To investigate epithelial and vascular changes in pediatric asthma.
  • To assess the inflammatory response within the airways of children with asthma.

Main Methods:

  • Analysis of bronchial biopsies from 44 children (17 mild/moderate asthma, 12 atopy without asthma, 15 controls).
  • Histochemistry and immunohistochemistry used to quantify epithelial loss, basement membrane thickness, vascularity, and inflammatory cells.
  • Stratified analysis by age was performed.

Main Results:

  • Children with asthma exhibited increased epithelial loss and basement membrane thickness compared to controls and atopic children.
  • Increased vascularity and eosinophils were observed in both asthmatic and atopic children without asthma, compared to controls.
  • Younger children (<6 years) with asthma showed significantly increased epithelial loss, basement membrane thickening, and eosinophilia.

Conclusions:

  • Pathological airway changes, characteristic of adult asthma, are present even in childhood asthma.
  • Airway eosinophilia and increased vascularity (angiogenesis) were also noted in atopic children without asthma.
  • These findings suggest that airway lesions develop early in asthma's natural history and may be indicative of atopy, even before asthma symptoms manifest.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...